Chao Liu | Biology and Life Sciences | Best Researcher Award

Dr. Chao Liu | Biology and Life Sciences | Best Researcher Award

Dongguan City University | China

Dr. Liu Chao (刘超), is a distinguished researcher in computational drug discovery and molecular simulation. With a robust background in Chemical Engineering and a Ph.D. from Nanyang Technological University, Singapore, he has seamlessly integrated computational techniques with biomedical applications. Dr. Liu has held prominent academic positions and has made impactful contributions in CADD, drug screening, and molecular dynamics. Currently serving as an Associate Professor at Dongguan City University, he continues to advance innovation in pharmacological sciences.

Professional profile👤

Google Scholar

Strengths for the Awards✨

Dr. Liu Chao is a highly accomplished researcher in the field of Computational Drug Discovery and Molecular Dynamics Simulation, with extensive expertise in CADD (Computer-Aided Drug Design), drug screening, and bioinformatics-based target validation. His research output demonstrates significant depth and interdisciplinary integration, particularly in targeted drug screening for conditions like autism, depression, gastric cancer, and osteoarthritis, as well as innovative use of molecular dynamics, MM/PBSA, and patch-clamp validation techniques.

He has been affiliated with premier institutions including Dongguan City University and Southern University of Science and Technology, where he held positions from Associate Professor to Senior Research Scholar. His educational pedigree spans from a Ph.D. at Nanyang Technological University with a solid GPA (4.37/5.0) to dual bachelor degrees from Tianjin University. His proficiency in computational tools (Python, Gromacs, Autodock Vina) and languages (C/C++) is at the expert level.

🎓 Education

Dr. Liu Chao holds a Ph.D. in Chemical Engineering (Molecular Simulation) from Nanyang Technological University, Singapore (2008–2012), where he earned an impressive GPA of 4.37/5.0. He previously completed his Master’s in Chemical Engineering (Process Simulation) at Tianjin University (2006–2008) and earned dual bachelor’s degrees in Chemical Engineering and Technology and Computer Science and Technology from Tianjin University, finishing first in his class. His academic excellence laid a strong foundation for his future success.

👨‍🔬 Experience

Dr. Liu’s career spans academia and industry, including roles as Senior Research Scholar at Southern University of Science and Technology (SUSTech) (2021–2023) and R&D Scientist at Process Integration Limited, Beijing (2013–2015). He has also held postdoctoral positions at SUSTech and Wuhan Institute of Technology. Since 2023, he has been serving as Associate Professor at Dongguan City University, where he leads drug discovery research. His work involves advanced simulation techniques, including patch-clamp validations and molecular docking for diseases such as osteoarthritis and autism.

🔍 Research Interests On Biology and Life Sciences

Dr. Liu’s research interests revolve around Computer-Aided Drug Design (CADD), Drug Development, Molecular Docking, ADMET Testing, and Molecular Dynamics Simulations. He has applied these tools to study drug interactions with proteins relevant to osteoarthritis, autism, depression, and gastric cancer. His interdisciplinary expertise bridges chemistry, biology, and computational modeling.

🏆 Awards

Dr. Liu has received numerous honors, including:

  • 2025 Candidate for Digital Expert in Guangdong Province

  • 2024 Qiming Initiative Finalist by MIIT of China

  • 2023 High-Level Talent in Dongguan City

  • 2022 Distinguished Expert – China Doctoral Association Think Tank

  • 2019 Overseas Young Postdoctoral Fellowship – Pearl River Talent Plan

  • 2011 Best Young Author Nominee – Molecular Physics
    Additionally, he is a member of IEEE since 2009 and has received scholarships and talent awards throughout his academic career, highlighting his outstanding contributions to science and technology.

📚 Publications

  • Water as a Direct Proton Source for Asymmetric Hydroarylation Catalyzed by a Rh(I)–Diene: Access to Nonproteinogenic β2/γ2/δ2-Amino Acid Derivatives
    Authors: JP Chen, Y Li, C Liu, T Wang, LW Chung, MH Xu
    Year: 2020
    Cited by: 9

  • Cryo-EM structures of ClC-2 chloride channel reveal the blocking mechanism of its specific inhibitor AK-42
    Authors: T Ma, L Wang, A Chai, C Liu, W Cui, S Yuan, S Wing Ngor Au, L Sun, …
    Year: 2023
    Cited by: 5

  • Cryo-EM structure and activator screening of human tryptophan hydroxylase 2
    Authors: K Zhu, C Liu, Y Gao, J Lu, D Wang, H Zhang
    Year: 2022
    Cited by: 4

  • Solubility correlation by model with partial molar volume
    Authors: Q Yu, J Li, C Liu, H Yang
    Year: 2023
    Cited by: 3

  • Direct Simulation Monte Carlo for Dense Hard Spheres
    Authors: L Chao, SK Kwak, S Ansumali
    Year: 2014
    Cited by: 2

  • Generalized equilibrium concentration of polyvacancy: case study for trivacancy in hard-sphere crystals
    Authors: C Liu, PC Su, SK Kwak
    Year: 2011
    Cited by: 1

  • Targeted drug screening for autism based on Cav1.2 calcium ion channel
    Author: C Liu
    Year: 2025
    Cited by: Not yet cited

  • Inhibitor screening for volume-sensitive LRRC8A chloride channel
    Authors: C Liu, W Cui, K Zhu, S Yuan, L Sun, Y Liang, J Lu, D Li, Z Deng, L Duan, …
    Year: 2024
    Cited by: Not yet cited

🧩 Conclusion

With a strong academic foundation, interdisciplinary research excellence, and an impressive portfolio of publications and awards, Dr. Liu Chao stands as a prominent leader in computational drug discovery. His commitment to using advanced simulations to address pressing medical challenges—from autism to gastric cancer—illustrates both scientific rigor and societal impact. Dr. Liu’s dynamic contributions make him a compelling candidate for any prestigious scientific or innovation-based recognition.

Katia Collomp | Health Sciences | Women Researcher Award

Prof. Dr. Katia Collomp | Health Sciences | Women Researcher Award

Professor, Orleans University | France

Professor Catherine (Katia) Collomp is a distinguished academic in Sport Sciences at the University of Orleans, France, and a Research Fellow at the French Antidoping Laboratory (LADF), University of Paris-Saclay. With an exceptional career dedicated to the intersection of pharmacology, exercise physiology, and anti-doping science, she is also a key member of the CIAMS laboratory. Her work has significantly influenced anti-doping policies and research ethics in sports science, making her a leading voice in the field.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  • Extensive Experience & Leadership
    Professor Collomp has over three decades of continuous and impactful contributions to sport sciences, pharmacology, and anti-doping research. Her role as a full professor and long-term research fellow at the French Antidoping Laboratory (LADF) demonstrates academic excellence and institutional commitment.

  • Interdisciplinary Expertise
    Her background as a pharmacist and researcher in physical activity and health sciences reflects a rare interdisciplinary blend that strengthens both the scientific rigor and practical impact of her work, especially in anti-doping studies—a field requiring deep knowledge of pharmacology, ethics, and sports physiology.

  • Global and National Collaborations
    Her postdoctoral research in Canada and continued collaborations with major institutions like University of Paris-Saclay and WADA position her as an internationally connected researcher. These connections indicate a high level of respect and trust in her expertise.

  • Institutional Service & Policy Impact
    Professor Collomp has held numerous leadership and advisory roles:

    • Co-director of the CIAMS lab team

    • Expert reviewer for HCERES

    • Member of ethics committees and national academic councils (CNU

🎓 Education

Katia Collomp began her academic journey by earning her degree in Pharmacy from the University of Montpellier I in 1987. She went on to complete her Ph.D. in 1991, focusing on “Physical activity, psychological and motor development” within the Life Sciences and Health section at the same university. 📘 Following her doctorate, she undertook a postdoctoral fellowship from 1992 to 1993 at the INRS Santé Antidoping Laboratory in Montréal, deepening her expertise in doping control and bioanalysis. She achieved her Habilitation à Diriger des Recherches (HDR) in 1997, establishing her as a senior scientific leader in her field.

💼 Experience

From 1993 to 1997, Katia served as a Pharmacist at the Mission Sports Medicine – Doping Control, Ministry of Sports in Paris, contributing to the foundation of anti-doping protocols. In 1997, she joined the French Antidoping Laboratory (LADF) as a Research Fellow, a position she continues to hold. Her academic path includes positions as Associate Professor (1997–2001) at the University of Paris XI and Full Professor (2001–present) at the University of Orleans. She has led multiple research teams and contributed to national committees on education and ethics.

🔬 Research Interest On Health Sciences

Her research interests span pharmacology, performance-enhancing substances, glucocorticoids, sports physiology, and rehabilitation. She focuses on the effects of physical activity on health and doping control, contributing to ethical frameworks and scientific methodologies that guide international sports policies. Her work helps shape understanding of how substances influence athletic performance and rehabilitation, playing a crucial role in global anti-doping efforts.

🏅 Awards & Honors

Professor Collomp has served in multiple national and international scientific committees, including as an expert for HCERES, a member of the WADA Glucocorticoids Threshold Working Group, and the Research Ethics Committee of Paris-Saclay (CER). She is currently a member of the French “Conseil National des Universités” (CNU 74), reflecting her respected status in the academic and sports science community. 🎖️ Her leadership and advocacy for scientific integrity in sports continue to influence generations of researchers and athletes alike.

📚 Publications

1. Hormonal and Metabolic Responses Across Phases of Combined Oral Contraceptive Use and Menstrual Cycle in Young Elite Female Athletes

  • Authors: Katia Collomp, Agnès Olivier, Caroline Teulier, Juliette Bonnigal, Nathalie Crépin, Corinne Buisson, Magnus Ericsson, Emmanuelle Duron, Eric Favory, Mathieu Zimmermann, et al.

  • Year: 2025

  • Journal: European Journal of Applied Physiology

  • DOI: 10.1007/s00421-025-05745-x

2. Impact of Menstrual Cycle and Oral Contraceptives on Haematological and Inflammatory Biomarkers in Highly Trained Female Athletes

  • Authors: Katia Collomp, Caroline Teulier, Carole Castanier, Juliette Bonnigal, Alexandre Marchand, Corinne Buisson, Magnus Ericsson, Nathalie Crépin, Emmanuelle Duron, Eric Favory, et al.

  • Year: 2025

  • Journal: Drug Testing and Analysis

  • DOI: 10.1002/dta.3859

3. Correlation Between Serum and Saliva Sex Hormones in Young Female Athletes

  • Authors: Katia Collomp, Agnès Olivier, Carole Castanier, Juliette Bonnigal, Valérie Bougault, Corinne Buisson, Magnus Ericsson, Emmanuelle Duron, Eric Favory, Mathieu Zimmermann, et al.

  • Year: 2025

  • Journal: The Journal of Sports Medicine and Physical Fitness

  • DOI: 10.23736/s0022-4707.24.16488-2

4. Editorial: Women in Sports 2022

  • Authors: Katia Collomp, S. Lorenzetti

  • Year: 2024

  • Journal: Frontiers in Physiology

  • DOI: 10.3389/fphys.2024.1367605

5. Physical Activity and Female Students’ Perception of Menstrual Symptoms: Impact of Hormonal Contraception

  • Authors: Katia Collomp, Sandrine Schiano-Lomoriello, Carole Castanier, Corinne Buisson, Magnus Ericsson, Caroline Teulier, Valérie Bougault

  • Year: 2024

  • Conference Paper: HAL: hal-04936867

  • Citations: 0

6. Correlation Between Serum and Saliva Sex Hormones in Young Female Athletes

  • Authors: Katia Collomp, Agnès Olivier, Carole Castanier, Caroline Teulier, Juliette Bonnigal, Valérie Bougault, Corinne Buisson, Magnus Ericsson, Emmanuelle Duron, Eric Favory, et al.

  • Year: 2024

  • Conference Paper: HAL: hal-04936872

7. Physical Activity and Combined Hormonal Contraception: Association with Female Students’ Perception of Menstrual Symptoms

  • Authors: Valérie Bougault, Sandrine Schiano-Lomoriello, Carole Castanier, Corinne Buisson, Magnus Ericsson, Caroline Teulier, Katia Collomp

  • Year: 2023

  • Journal: Frontiers in Physiology

  • DOI: 10.3389/fphys.2023.1185343

8. Short-Term Effect of Bariatric Surgery on Cardiorespiratory Response at Submaximal, Ventilatory Threshold, and Maximal Exercise in Women with Severe Obesity

  • Authors: Nancy Vibarel-Rebot, Marine Asselin, Virgile Amiot, Katia Collomp

  • Year: 2023

  • Journal: Obesity Surgery

  • DOI: 10.1007/s11695-023-06550-1

9. Summer Olympic Sports and Female Athletes: Comparison of Anti-Doping Collections and Prohibited Substances Detected in Australia and New Zealand vs. France

  • Authors: Corinne Buisson, L. Brooker, C. Goebel, R. Morrow, R. Chakrabarty, N. Speers, A. Molina, Magnus Ericsson, Katia Collomp

  • Year: 2023

  • Journal: Frontiers in Sports and Active Living

  • DOI: 10.3389/fspor.2023.1213735

10. Prevalence of Prohibited Substance Use and Methods by Female Athletes: Evidence of Gender-Related Differences

  • Authors: Katia Collomp, Magnus Ericsson, N. Bernier, Corinne Buisson

  • Year: 2022

  • Journal: Frontiers in Sports and Active Living

  • DOI: 10.3389/fspor.2022.839976

🔚 Conclusion

Professor Catherine Collomp exemplifies the union of scientific excellence, ethical integrity, and academic leadership in the field of sport sciences and pharmacology. Her dedication to clean sport, athlete health, and rigorous scientific inquiry continues to guide anti-doping practices across the globe. Her nomination for any award would reflect her lifelong commitment to advancing science in service of both health and fairness in athletics.